**Background and Purpose** MERS-CoV, a highly pathogenic virus in humans, is associated with high morbidity and case fatality. Inflammatory responses have a significant impact on MERS-CoV pathogenesis and disease outcome. However, CD4+ T-cell induced immune responses during acute MERS-CoV infection are barely detectable, with potent inhibition of effector T cells and downregulation of antigen presentation. The local pulmonary immune response, particularly the Th1/Th2 immune response during acute MERS-CoV infection is not fully understood. The purpose of this study was to study the pulmonary gene expression profile of Th1 and Th2-related cytokines, chemokines, and receptors (Th1 & Th2 responses) during acute MERS-CoV infection using RT^2^ Profiler PCR Arrays and expression level of primary inflammatory cytokines/chemokines. Results and Discussions: Our results showed a downregulation of Th2, inadequate (partial) Th1 immune response and high expression levels of inflammatory cytokines IL-1 α and IL-1 β and the neutrophil chemoattractant chemokine IL-8 (CXCL8) in the lower respiratory tract of MERS-CoV infected patients. Moreover, we identified a high viral load in all included patients.Genes encoding Th1 and Th2 cytokines/chemokines were largely downregulated in the lower respiratory tract of MERS-CoV infected patients, with selective upregulation of IL-18, CXCR3, SOCS5, and CCR2. It is possible that overexpression of IL-1 α, IL-1 β, IL-8 (CXCL8), IL-18, CXCR3, SOCS5, and CCR2 play a vital role in the severity, immunopathology, and case fatality of MERS-CoV infected patients. We observed a correlation between inflammatory cytokines, Th1, and Th2 downregulation and the case fatality rate.

**Conclusions** Th1 and Th2 response downregulation, high expression of inflammatory cytokines, and high viral load may contribute to lung inflammation, severe infection, the evolution of pneumonia and ARDS, and a higher case fatality rate. Further study of the molecular mechanisms underlying the Th1 and Th2 regulatory pathways will be vital for active vaccine development and the identification of novel therapeutic strategies.
